The see-saw of Keap1-Nrf2 pathway in cancer

Poorti Pandey1, Alok Kumar Singh1, Mritunjai Singh1

  • 1Department of Medicine, Faculty of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, 221005, India.

Insights

The Keap1-Nrf2 pathway protects cells from oxidative stress. Dysregulation of this pathway may promote tumor growth, highlighting its importance in cancer prevention and treatment.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cellular Biology

Background:

  • The Keap1-Nrf2 pathway is crucial for cellular defense against oxidative stress.
  • Nrf2 (Nuclear factor erythroid 2-related factor 2) regulates cytoprotective genes following oxidative insults.
  • Keap1 (Kelch-like ECH-associated protein 1) acts as a negative regulator of Nrf2 at the post-transcriptional level.

Purpose of the Study:

  • To critically analyze the dual role of the Keap1-Nrf2 pathway in cytoprotection and potential tumor promotion.
  • To elucidate the current understanding of this pathway's involvement in cellular defense mechanisms.
  • To explore novel therapeutic strategies for cancer prevention and treatment based on Keap1-Nrf2 pathway modulation.

Main Methods:

  • Literature review and critical analysis of existing scientific data.
  • Examination of studies investigating the Keap1-Nrf2 interaction and its functional consequences.
  • Synthesis of information regarding the pathway's role in both protective and potentially oncogenic processes.

Main Results:

  • The Keap1-Nrf2 pathway is a well-established mediator of cellular responses to oxidative stress.
  • Post-transcriptional regulation by Keap1 is key to controlling Nrf2 activity.
  • Aberrant Keap1-Nrf2 pathway function is implicated in tumor development.

Conclusions:

  • The Keap1-Nrf2 pathway plays a significant role in maintaining cellular homeostasis against oxidative damage.
  • Understanding the pathway's dysregulation is essential for developing targeted cancer therapies.
  • Further research into this pathway may reveal new avenues for cancer chemoprevention and treatment.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.1K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.9K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K